23and me stock.

ME | 28 minutes ago. NEW YORK, NY / ACCESSWIRE / December 4, 2023 / 23andMe, a popular personal genomics and DNA analysis company run by 23andMe Holding Co. ("23 and Me") (NASDAQ:ME), recently suffered a massive data leak. The attack targeted the personal information of 23andMe users -more than 4 million people- compromising individual's ...23andMe Says Health Data Was Included in Hack That Compromised 6.9 Million Users. Some 6.9 million 23andMe customers had their data compromised after an …Oct 22, 2021 · Under the merger agreement, the purchase price is $400 million (subject to certain customary downward adjustments), of which 25% will be paid in cash and 75% in shares of 23andMe Class A Common Stock. 23andMe entered its IPO with two down years on revenue but has since reclaimed low double-digit growth. Find out why ME stock is a Hold.

Nov 28, 2023 · 27.2%. -28.6%. Market Cap. The market value of a company, in total dollars, also called "market capitalization." Market cap is calculated by taking a company's price per share and multiplying it ...

Industry. Biotechnology. No executives to display. Corporate headquarters. --, --. Find real-time ME - 23andMe Holding Co. stock quotes, company profile, news and forecasts from CNN Business.

19 de nov. de 2022 ... ... stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help ...17 de ago. de 2021 ... 23andMe has 'a core competitive advantage that is not easily replicated,' Credit Suisse says.Combined Company to Trade on Nasdaq Under Ticker “ME” Commencing June 17SUNNYVALE, Calif. and NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- 23andMe, Inc., a leading consumer genetics and ...View 23andMe Holding Co ME investment & stock information. Get the latest 23andMe Holding Co ME detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

SUNNYVALE, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, today announced that it has completed its previously-announced acquisition of Lemonaid Health, Inc. (“Lemonaid Health”), an on-demand platform for accessing …

Find out the direct holders, institutional holders and mutual fund holders for 23andMe Holding Co. (ME).

ME - 23andMe Holding Co. Stock quote - CNNMoney.com Tech Media Success Video 23andMe Holding Co. (NASDAQ:ME) 0.8501 Delayed Data As of Nov 17 +0.0873 / …Analyst Report: 23andMe Holding Co. 23andMe is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA ...What happened. The stock market was experiencing a frothy Friday on the last trading day of the week, but 23andMe Holding (ME 1.82%) was a bit of a wallflower at the party. As of 1:30 p.m. ET ...23andMe Holding Co. (ME) latest earnings report: revenue, EPS, surprise, history, news and analysis.Stock price history for 23andMe (ME) Highest end of day price: $17.65 USD on 2021-02-04. Lowest end of day price: $0.71 USD on 2023-11-09. Stock price history of 23andMe from 2020 to 2023. What is the market capitalization of a company?Stock Ticker Symbol Market Type; 23andMe Holding Company: ME: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded . 0.08375: 10.98%: 0.84655: 15:34:42: Open Price Low PriceJun 9, 2021 · Meanwhile, at VGAC’s current stock price, 23andMe is valued at around $4.56 billion. After adjusting for its pro forma $984 million net cash, it would have an EV (enterprise value) of $3.58 ...

View 23andMe Holding Co ME investment & stock information. Get the latest 23andMe Holding Co ME detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Under the merger agreement, the purchase price is $400 million (subject to certain customary downward adjustments), of which 25% will be paid in cash and 75% in shares of 23andMe Class A Common Stock. The acquisition is expected to close by the end of 2021. The acquisition adds Lemonaid Health’s innovative telemedicine and …Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...Get the detailed quarterly/annual income statement for 23andMe Holding Co. (ME). Find out the revenue, expenses and profit or loss over the last fiscal year.5 hours ago · 23andMe (ME) stock gained ~11% on Monday after announcing that hackers accessed only 0.1% of customer accounts during a recent data breach. Read more here.

What is 23andMe's consensus rating and price target? According to the issued ratings of 1 analysts in the last year, the consensus rating for 23andMe stock is Buy based on the current 1 buy rating for ME. The average twelve-month price prediction for 23andMe is $1.75 with a high price target of $1.75 and a low price target of $1.75.

27.55%. Get the latest 23andMe Holding Co. (ME) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.23andMe Holding Co. analyst ratings, historical stock prices, earnings estimates & actuals. ME updated stock price target summary.Funding. 23andMe has raised a total of. $1.1B. in funding over 19 rounds. Their latest funding was raised on Jun 17, 2021 from a Post-IPO Equity round. 23andMe is registered under the ticker NASDAQ:ME . 23andMe is funded by 39 investors. Richard Branson and Altimeter Capital are the most recent investors. 23andMe has a post-money valuation in ...Nov 15, 2021 · Things got even worse today, when investors responded to a downgrade of 23andMe stock by a Citigroup analyst -- by selling off the stock by 10.1% (as of 11:30 a.m. EST). Image source: Getty Images ... ME. +10.27%. DNA-testing company 23andMe confirmed Monday that information about 6.9 million people, about half of its 14 million customers, was accessed …23andMe has 1 employees at their 1 location and $299.49 m in annual revenue in FY 2023. See insights on 23andMe including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. ... 23andMe stock jumps more than 12% on raised 2023 guidance. Feb 8, 2023. 23andMe to Report FY2023 Third …

Nov 22, 2021 · In addition, 23andMe will redeem all of its outstanding warrants to purchase Class A common stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO ...

8 de ago. de 2022 ... (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research ... Common Stock - Class A shares, par value $0.0001, 1,140,000,000 shares ...

23andMe Holding Co. historical stock charts and prices, analyst ratings, financials, and today’s real-time ME stock price.23andMe Holding Co. (NASDAQ:ME) Q2 2024 Earnings Call Transcript November 8, 2023 23andMe Holding Co. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.14 ...SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, reported its financial results for the first quarter (Q1) of fiscal year 2024 (FY2024), which ended June 30, 2023. 23andMe is the only company with multiple U.S. Food and Drug ...Citigroup Adjusts 23andMe Price Target to $2.50 From $3.75, Maintains Neutral Rating. May. 26. MT. Berenberg Bank Initiates Coverage on 23andMe Holding With Buy Rating, $7 Price Target. Nov. 29. MT. Credit Suisse Trims 23andMe Holding's Price Target to $6 From $7, Keeps Outperform Rating. Nov. 08. MT.Nov 29, 2023 · What is 23andMe's consensus rating and price target? According to the issued ratings of 1 analysts in the last year, the consensus rating for 23andMe stock is Buy based on the current 1 buy rating for ME. The average twelve-month price prediction for 23andMe is $1.75 with a high price target of $1.75 and a low price target of $1.75. Aug 13, 2021 · FY2022 First Quarter Financial Results. Total revenue was $59 million for the quarter ended June 30, 2021, representing an increase of $11 million or 23%, year over year. This revenue growth was primarily due to higher Personal Genome Service (PGS) kit sales, which resulted from increased marketing spending and growth in consumer demand. 17 de jun. de 2021 ... New York Stock Exc... ... No photo description available. Webull. 󱢏. Financial ...The combined company is called 23andMe Holding Co. and will be traded on The Nasdaq Global Select Market (“Nasdaq”) beginning on June 17, 2021 under the new ticker symbol “ME” for its ...The SPAC merger gave 23andMe an equity value of $4.45 billion, and its stock surge boosted its equity value to around $5.92 billion. After adjusting for its $984 million in pro forma net cash, we ...23andMe Holding Co. historical stock charts and prices, analyst ratings, financials, and today’s real-time ME stock price. Citigroup Adjusts 23andMe Price Target to $2.50 From $3.75, Maintains Neutral Rating. May. 26. MT. Berenberg Bank Initiates Coverage on 23andMe Holding With Buy Rating, $7 Price Target. Nov. 29. MT. Credit Suisse Trims 23andMe Holding's Price Target to $6 From $7, Keeps Outperform Rating. Nov. 08. MT.Full-year revenue guidance of $260-280 million was reiterated, but adjusted EBITDA loss guidance of $195-215 million remains disappointing. With the company's enterprise value now under $1 billion ...

Anne Wojcicki is the CEO and Co-Founder of 23andMe. She co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was audacious: to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process. Prior to founding 23andMe, Anne spent …See 23andMe Holding Co. (ME) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.23andMe, Inc. SUNNYVALE, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will ...Track 23andMe Holding Co - Ordinary Shares - Class A (ME) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Instagram:https://instagram. bsgm tickerhotel reits listhlbz newstrading automation 23andMe Holding Co. Watch list NEW Set a price target alert Open Last Updated: Nov 30, 2023 1:01 p.m. EST Real time quote $ 0.8865 -0.0091 -1.02% Previous Close $0.8956 Advanced Charting Volume:... nvda next earnings datebest checking accounts in tennessee 4 de ago. de 2021 ... 23andMe completes merger with Richard Branson's VG Acquisition Corp. and is now trading stock on NASDAQ.ME 23andMe Holding Company. 0.8589. 0.0961 ( 12.6% ) Nov 17 2023 - Closed. Delayed by 15 minutes. Quote. Board. Chart. Level 2. anthem insurance review See the company profile for 23andMe Holding Co. (ME) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ... Nov 30, 2023 · A. The latest price target for 23andMe Holding ( NASDAQ: ME) was reported by Citigroup on Thursday, August 10, 2023. The analyst firm set a price target for 1.75 expecting ME to rise to within 12 ...